PAX2 in endometrial carcinogenesis and in differential diagnosis of endometrial hyperplasia. A systematic review and meta ‐analysis of diagnostic accuracy

ConclusionsPAX2 seems to behave as tumor suppressor in endometrial carcinogenesis. PAX2 is an accurate marker of precancerous EH; complete loss of PAX2 and EIN classification appear as the optimal diagnostic criteria.This article is protected by copyright. All rights reserved.

Source: Acta Obstetricia et Gynecologica Scandinavica - December 4, 2018 Category: OBGYN Authors: Antonio Raffone, Antonio Travaglino, Gabriele Saccone, Massimo Mascolo, Luigi Insabato, Antonio Mollo, Giuseppe De Placido, Fulvio Zullo Tags: Systematic review Source Type: research